ResMed
485 hedge funds and large institutions have $11.8B invested in ResMed in 2019 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 159 increasing their positions, 191 reducing their positions, and 49 closing their positions.
29% more call options, than puts
Call options by funds: $28M | Put options by funds: $21.6M
27% more first-time investments, than exits
New positions opened: 62 | Existing positions closed: 49
25% more funds holding in top 10
Funds holding in top 10: 4 → 5 (+1)
16% more capital invested
Capital invested by funds: $10.2B → $11.8B (+$1.61B)
2% more funds holding
Funds holding: 477 → 485 (+8)
0.94% less ownership
Funds ownership: 68.31% → 67.37% (-0.94%)
17% less repeat investments, than reductions
Existing positions increased: 159 | Existing positions reduced: 191
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$146M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
+$59.7M |
| 3 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
+$34.4M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.5M |
| 5 |
WCM Investment Management
Laguna Beach,
California
|
+$17.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$57.4M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$52.5M |
| 3 |
BlackRock
New York
|
-$30M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$20.2M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$18M |
RMD Hedge Fund Activity: Q2 2019 in Review
485 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q2 2019, worth a combined $11.8B — up 16% from $10.2B a quarter earlier.
Buyers outnumbered sellers: 62 funds opened new RMD positions and 49 closed out — a net gain of 13 holders — while 159 added to existing stakes and 191 trimmed.
The largest buyer was Invesco, adding an estimated $146M. The largest seller was Fidelity Investments, cutting an estimated $57.4M.
- 485 institutional investors held ResMed (RMD) as of Q2 2019, up from 477 in Q1 2019.
- Funds reported $11.8B of ResMed stock for Q2 2019, up 16% quarter-over-quarter.
- 62 funds opened new ResMed positions in Q2 2019 and 49 closed out, a net change of +13 holders.
- The largest ResMed buyer in Q2 2019 was Invesco, an estimated $146M added.
- The largest ResMed seller in Q2 2019 was Fidelity Investments, an estimated $57.4M sold.
Based on aggregated 13F filings for Q2 2019.